Detalles de la búsqueda
1.
Variation in Pharmacologic Management of Patients with Kawasaki Disease with Coronary Artery Aneurysms.
J Pediatr
; 240: 164-170.e1, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34474088
2.
Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades.
Pediatr Cardiol
; 42(3): 676-684, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33439285
3.
Associations between the spatiotemporal distribution of Kawasaki disease and environmental factors: evidence supporting a multifactorial etiologic model.
Sci Rep
; 11(1): 14617, 2021 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34272416
4.
Bleeding risk associated with combination thromboprophylaxis therapy is low for patients with coronary artery aneurysms after Kawasaki disease.
Int J Cardiol
; 321: 6-11, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32697954
5.
Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry.
J Am Heart Assoc
; 9(15): e016440, 2020 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32750313
6.
Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial.
Can J Cardiol
; 36(10): 1598-1607, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32621885
7.
Compound heterozygous variants in IFT140 as a cause of nonsyndromic retinitis pigmentosa.
Ophthalmic Genet
; 39(2): 286-287, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29111861
Resultados
1 -
7
de 7
1
Próxima >
>>